Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
ES30 - Leveraging the Power of Immunotherapy for SCLC
- 10:45 - 11:45
- 8/09/2022
- Location: Strauss 1/2
- IASLC CME Accredited
- Type: Education Session
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Moderators:Giorgio Scagliotti, Raffaele Califano
-
+
Session Moderator
10:45 - 10:46 | Presenter: Giorgio Scagliotti
- Abstract
Loading... -
+
Session Moderator
10:45 - 10:46 | Presenter: Raffaele Califano
- Abstract
Loading... -
+
ES30.01 - Session Introduction
10:45 - 10:46 | Presenter: Giorgio Scagliotti
- Abstract
Loading... -
+
ES30.02 - Session Introduction
10:46 - 10:47 | Presenter: Raffaele Califano
- Abstract
Loading... -
+
ES30.03 - Transcriptional Subtypes and Impact of Immune Checkpoint Inhibitors
10:47 - 10:59 | Presenter: Christine Hann
- Abstract
Loading... -
+
ES30.04 - State of the Art and Perspectives in Limited Stage SCLC
10:59 - 11:11 | Presenter: Sumitra Thongprasert
- Abstract
Loading... -
+
ES30.05 - Novel Strategies Other Than IO in the Front-Line Setting
11:11 - 11:23 | Presenter: Jens Benn Sørensen
- Abstract
Loading... -
+
ES30.06 - Novel Immunotherapies Beyond PD-(L1) and CTLA-4 Inhibition
11:23 - 11:35 | Presenter: Egbert Smit
- Abstract
Loading... -
+
ES30.07 - Live Q&A
11:35 - 11:45
- Abstract
Loading...
